<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="retraction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2017.02363</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: Pseudopyronine B: A Potent Antimicrobial and Anticancer Molecule Isolated from a <italic>Pseudomonas mosselii</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by"><p>Approved by: Rustam Aminov, University of Aberdeen, United Kingdom</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Frontiers Editorial Office <email>editorial.office&#x00040;frontiersin.org</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>2363</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front Microbiol" journal-id-type="nlm-ta" vol="7" page="1307" xlink:href="27617005" ext-link-type="pubmed">A retraction of the Original Research Article <article-title>Pseudopyronine B: A Potent Antimicrobial and Anticancer Molecule Isolated from a <italic>Pseudomonas mosselii</italic></article-title> by Nishanth Kumar, S., Aravind, S. R., Jacob, J., Gopinath, G., Lankalapalli, R. S., Sreelekha, T. T., et al. (2016). Front. Microbiol. 7:1307. doi: <object-id>10.3389/fmicb.2016.01307</object-id></related-article>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="261"/>
</counts>
</article-meta>
</front>
<body>
<p>This paper is retracted by Frontiers. The publisher has discovered that the author(s) created and provided false information for the peer-review process. As the scientific integrity of the article cannot be guaranteed, and adhering to the recommendations of the Committee on Publication Ethics (COPE), the publisher therefore retracts the article.</p>
<p>The retraction of the article was approved by the Field Chief Editor of Frontiers in Microbiology.</p>
</body>
</article>